API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
API
BP/USP
C20H21CLO4
(5α,17β)-N-{1,1-Dimethylethyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide
98319-26-7
360.83 g/mol
Phenoxyisobutyric acid derivative
Alpha Reductase Inhibitor
| Appearance | Off-White Crystalline Solid |
|---|---|
| Solubility | Practically insoluble in water; soluble in methanol, ethanol, and acetone |
| Melting Point | 253–257°C |
| pH | - |
Finasteride is a medication that belongs to the class of 5-alpha reductase inhibitors. It works by blocking the conversion of testosterone to dihydrotestosterone (DHT), a hormone involved in the development of conditions like benign prostatic hyperplasia (BPH) and male pattern baldness. Finasteride is commonly prescribed to treat enlarged prostate and to promote hair growth in men with androgenetic alopecia. It helps reduce prostate size, improve urinary symptoms, and slow hair loss progression.
Finasteride works by inhibiting the enzyme 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT). Since DHT is a key hormone responsible for prostate enlargement and hair follicle shrinkage in male pattern baldness, blocking its production helps reduce prostate size and slows or reverses hair loss.
| Attribute | Why Salius Pharma Is a Good Choice |
|---|---|
| Quality Certification | WHO GMP, ISO 9001:2015, FDA audited facilities |
| Affordability & Generic Access | Cost competitive generics for global supply |
| Export Experience | Proven track record of supplying globally |
When you order from Salius Pharma, you receive more than just a product — you receive a complete, professionally prepared package that meets international regulatory and quality expectations.
We ensure prompt and reliable shipping worldwide. Delivery times vary depending on destination, order volume, and regulatory requirements.
7 to 21 business days from dispatch, depending on your location.
It’s used to treat enlarged prostate (BPH) and male pattern baldness by reducing DHT levels.
It inhibits 5-alpha reductase, lowering DHT hormone levels that cause prostate growth and hair loss.
It is not approved for use in women, especially during pregnancy, due to risk of birth defects.
Yes — Salius Pharma Pty. Ltd. exports Finasteride API to both African and Middle Eastern countries, leveraging its global reach and regulatory-compliant manufacturing capabilities. Trade data from India shows that Finasteride was exported to Middle East countries like United Arab Emirates and South Africa in Africa, indicating strong market presence in both regions.
Looking to source Finasteride or other high-quality pharmaceutical products?
We’re here to help.
Whether you need Active Pharmaceutical Ingredients (APIs), finished formulations, or regulatory support,
our team is ready to provide dependable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.